Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,475.00p
   
  • Change Today:
    -50.00p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,079
  • Market Cap: £233.58m

Bioventix appoints Bruce Hiscox as chief financial officer

By Iain Gilbert

Date: Wednesday 01 Jul 2020

LONDON (ShareCast) - (Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.
Hiscock, previously chief executive and CFO of everyLIFE Technologies, a technology business delivering digital care planning solutions to social care providers, will start in the role with immediate effect.

The AIM-listed group highlighted that Hiscock had held several CFO roles at both fast-growing listed and private companies over his 30-year career and was a member of the Institute of Chartered Accountants of Scotland.

As of 0940 BST, Bioventix shares were up 1.20% at 4,200p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,475.00p
Change Today -50.00p
% Change -1.11 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 1,079
Shares Issued 5.22m
Market Cap £233.58m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.56% above the market average78.56% above the market average78.56% above the market average78.56% above the market average78.56% above the market average
92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average
Income
30.49% below the market average30.49% below the market average30.49% below the market average30.49% below the market average30.49% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
35.7% below the market average35.7% below the market average35.7% below the market average35.7% below the market average35.7% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 23-Apr-2024

Time Volume / Share Price
16:16 98 @ 4,450.00p
16:14 44 @ 4,480.00p
14:26 100 @ 4,485.00p
14:16 245 @ 4,487.00p
14:00 340 @ 4,489.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page